PCI The Journeys Within
CPHI 2026 – 23/07/2026

Current Edition

ramusmedical
Europe

North Estonia Medical Centre has joined the network of hospitals on Clinerion’s Patient Network Explorer platform.

North Estonia Medical Centre (NEMC) consists of seven clinics and 32 specialist centers, and is the most important caregiver in the capital of Estonia, Tallinn, as we...
Continue Reading →
news

AbbVie and J&J dominate clinical trial development in psoriatic arthritis, says GlobalData

AbbVie and Johnson & Johnson (J&J) are responsible for 47 of the 121 industry sponsored clinical trials in the psoriatic arthritis space, according to GlobalD...
Continue Reading →
news

PCI Pharma Services Announces a more than $20 Million Expansion of Biotech Technologies Including Advanced Injectable Delivery Forms

Philadelphia, USA – January 07, 2019 Leading global biopharmaceutical services provider PCI Pharma Services (PCI) has announced a momentous investment in support of b...
Continue Reading →
Europe

WU biomedical engineer makes a significant step toward precision medicine

In 2015, then President Barack Obama launched a precision medicine initiative, saying that its promise was "delivering the right treatments, at the right time, every ...
Continue Reading →
Europe

Sutimlimab shows promise for hard-to-treat, rare blood disorder

In a first-in-human clinical trial reported today in Blood, the investigational drug sutimlimab appeared to be effective in treating cold agglutinin disease, a rare c...
Continue Reading →
Europe

First line immunotherapy combination fails to improve overall survival in lung cancer

First line immunotherapy with durvalumab or the combination of durvalumab and tremelimumab does not improve overall survival in unselected patients with lung cancer, ...
Continue Reading →
news

XBiotech Announces Publication of Post-Hoc Analysis for Phase III Colorectal Cancer Study

Biomarkers Predict Significantly Higher Rates of Treatment Response to Bermekimab in Advanced Cancer Patients AUSTIN, Texas, Dec. 13, 2018 (GLOBE NEWSWIRE) -- XBiotec...
Continue Reading →
Europe

Minoryx Therapeutics announces early completion of patient randomization in the ADVANCE trial: a phase 2/3 clinical study of MIN-102 in X-ALD patients

Mataró, Barcelona, Spain, December 12, 2018 – Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, today announces that i...
Continue Reading →
Europe

Shivom Partners With Lifebit To Power AI-Analysis of DNA Data For Clinical Trials

Blockchain genomics pioneer and AI data analysis firm will provide pharmaceutical organisations and life science users with comprehensive reporting through a library ...
Continue Reading →
Europe

Asarina Pharma Scientific Advisory Board gives full backing to Menstrual Migraine Phase IIA trial

Stockholm – December 18, 2018. On December 17 Asarina Pharma’s Scientific Advisory Board (SAB) gave its full backing to the company’s upcoming trial of a new prevent...
Continue Reading →
Quotient
CPHI 2026 – 20/07/2026